A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer
NCT06451445
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DEVICE:
Irreversible Electroporation (NanoKnife)
Sponsor
University Health Network, Toronto